Fibulins and cancer: friend or foe?

被引:119
|
作者
Gallagher, WM [1 ]
Currid, CA [1 ]
Whelan, LC [1 ]
机构
[1] Univ Coll Dublin, Dept Pharmacol, Ctr Mol Med, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland
基金
爱尔兰科学基金会;
关键词
D O I
10.1016/j.molmed.2005.06.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The fibulins are a family of secreted glycoproteins, which are characterised by repeated epidermal-growth-factor-like domains and a unique C-terminal structure. Six distinct fibulin genes, encoding at least nine protein products generated by alternative splicing, have been identified. Considerable evidence is available pointing towards a structural role for fibulins within the extracellular matrix. Fibulins have been shown to modulate cell morphology, growth, adhesion and motility. The dysregulation of certain fibulins occurs in a range of human disorders, including cancer. Indeed, both tumour suppressive and oncogenic activities have been proposed for members of the fibulin family. Herein, we discuss the possible roles of fibulins in cancer, in addition to their diagnostic and therapeutic potential.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 50 条
  • [21] Fibroblasts in cancer dormancy: foe or friend?
    Dai, Li
    Li, Mao
    Zhang, Wei-long
    Tang, Ya-Jie
    Tang, Ya-ling
    Liang, Xin-hua
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [22] Chemotherapy: Friend or foe to cancer vaccines?
    Emens, LA
    Machiels, JP
    Reilly, RT
    Jaffee, EM
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (01) : 77 - 84
  • [23] Rho GTPases in cancer: friend or foe?
    Svensmark, Julius H.
    Brakebusch, Cord
    [J]. ONCOGENE, 2019, 38 (50) : 7447 - 7456
  • [24] Sulfonylurea derivatives and cancer, friend or foe?
    Hendriks, Anne M.
    Schrijnders, Dennis
    Kleefstra, Nanne
    de Vries, Elisabeth G. E.
    Bilo, Henk J. G.
    Jalving, Mathilde
    Landman, Gijs W. D.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 861
  • [25] Autophagy: Cancer's Friend or Foe?
    Bhutia, Sujit K.
    Mukhopadhyay, Subhadip
    Sinha, Niharika
    Das, Durgesh Nandini
    Panda, Prashanta Kumar
    Patra, Samir K.
    Maiti, Tapas K.
    Mandal, Mahitosh
    Dent, Paul
    Wang, Xiang-Yang
    Das, Swadesh K.
    Sarkar, Devanand
    Fisher, Paul B.
    [J]. ADVANCES IN CANCER RESEARCH, VOL 118, 2013, 118 : 61 - 95
  • [26] Autophagy: Is it cancer's friend or foe?
    Marx, J
    [J]. SCIENCE, 2006, 312 (5777) : 1160 - 1161
  • [27] Alternative nutrition in cancer: friend or foe?
    Holmes, S
    [J]. JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2003, 123 (02): : 76 - 76
  • [28] Ferroptosis: friend or foe in cancer immunotherapy?
    Demuynck, Robin
    Efimova, Iuliia
    Catanzaro, Elena
    Krysko, Dmitri, V
    [J]. ONCOIMMUNOLOGY, 2023, 12 (01):
  • [29] Neutral Sphingomyelinases in Cancer: Friend or Foe?
    Clarke, Christopher J.
    [J]. SPHINGOLIPIDS IN CANCER, 2018, 140 : 97 - 119
  • [30] Fibroblasts in cancer dormancy: foe or friend?
    Li Dai
    Mao Li
    Wei-long Zhang
    Ya-Jie Tang
    Ya-ling Tang
    Xin-hua Liang
    [J]. Cancer Cell International, 21